In 120 patients with symptomatic paradoxical low-flow, low-gradient aortic stenosis, TAVR plus medical therapy did not significantly reduce death vs medical therapy alone (29.0% vs 37.1%; HR 0.83, P=0.60). Trial stopped early for slow recruitment (783 planned); 19 crossed over.
RCTn = 120
Mehilli et al. Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX